Actively Recruiting
CorEvitas Alopecia Areata (AA) Safety and Effectiveness Registry
Led by CorEvitas · Updated on 2026-02-09
5000
Participants Needed
1
Research Sites
4027 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Prospective, observational cohort study for subjects with AA under the care of a dermatology provider. Approximately 5,000 subjects and 100 clinical sites in North America will be recruited to participate with no defined upper limit for either target.
CONDITIONS
Official Title
CorEvitas Alopecia Areata (AA) Safety and Effectiveness Registry
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of alopecia areata by a dermatologist or qualified dermatology practitioner
- Age 18 years or older
- Willingness to provide personal information
- Currently prescribed or starting an enrollment eligible medication for alopecia areata at enrollment
You will not qualify if you...
- Participating or planning to participate in a double-blind randomized trial for an alopecia areata drug
- Concurrent participation in other observational registries or open-label Phase 3b/4 trials is allowed
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
CorEvitas, LLC
Waltham, Massachusetts, United States, 02451
Actively Recruiting
Research Team
C
Cathy Cheney
CONTACT
R
Resham Sanzagiri
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here